Endo Inc

OTCQX US:NDOIUnited States

Endo, Inc. is a diversified specialty pharmaceutical company, which is engaged in transforming insights into life-enhancing therapies. The Company’s segments include Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. Its Branded Pharmaceuticals segment focuses on products that have inherent scientific, regulatory, legal and/or technical complexities and are marketed under recognizable brand names that are trademarked. Its Sterile Injectables segment includes a broad portfolio of approximately 40 critical care, maternal health, anesthesia and other products. Its Generic Pharmaceuticals segment includes a portfolio of approximately 85 generic product families, including solid oral extended-release products, solid oral immediate release products, liquids, semi-solids, and others. Its International Pharmaceuticals segment sells a variety of specialty pharmaceutical products outside the United States, primarily to customers in Canada.

Contact Information

Headquarters

1400 Atwater DriveMALVERN, PA, United States 19355

Phone

484-216-0000

Fax

302-655-5049

Executives

Independent Chairman of the Board

Paul Herendeen

President, Chief Executive Officer, Director

Blaise Coleman

Chief Financial Officer, Executive Vice President

Mark Bradley

Executive Vice President, Chief Legal Officer, Secretary

Matthew Maletta

Executive Vice President, President, Global Commercial Operations

Patrick Barry